Elevance Health (ELV) said Thursday it expects to report Q1 adjusted net income of $11.97 per diluted share, up from $10.64 per share a year ago.
Analysts polled by FactSet expected $11.32.
The company said it plans to reaffirm its full-year 2025 adjusted net income guidance of $34.15 to $34.85 per diluted share. It plans to report its Q1 results April 22.
Price: 424.73, Change: -10.31, Percent Change: -2.37
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。